利博西林用於製備治療罹患磷酸二酯酶4介導疾病的患者的醫藥組合物及用途

Translated title of the contribution: PHARMACEUTICAL COMPOSITION AND USE FOR APPLYING RIBOCICLIB IN PHOSPHODIESTERASE 4-MEDIATED DISEASE TREATMENT OF PATIENT

Research output: Patent

Abstract

一種癌症狀態預測方法,藉由將血液檢體中的特定細胞資訊以及癌症臨床檢測資料,共同癌症狀態分析模組進行分析,進一步執行癌症狀態之預測。
Translated title of the contributionPHARMACEUTICAL COMPOSITION AND USE FOR APPLYING RIBOCICLIB IN PHOSPHODIESTERASE 4-MEDIATED DISEASE TREATMENT OF PATIENT
Original languageChinese (Traditional)
Patent numberI768713
IPCG01N 33/574(2006.01); A61B 5/1455(2006.01); G01N 33/49(2006.01)
StatePublished - 21 06 2022

Bibliographical note

公開公告號: I768713
Announcement ID: I768713

Cite this